These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 896833)

  • 41. Mechanisms involved in generation of oscillatory afterpotentials in myocardium.
    Nilius B; Albitz R; Linde T
    Biomed Biochim Acta; 1988; 47(2):163-71. PubMed ID: 3178782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial transmembrane potentials and adrenergic receptors.
    Somani P; Guse P; Toscano P; Bassett AL
    Adv Myocardiol; 1980; 1():189-207. PubMed ID: 6248934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of the positive inotropic and pressor effects of ouabain in nephrectomized dogs.
    Scriabine A; Stavorski JM
    Experientia; 1971 Mar; 27(3):295-6. PubMed ID: 5546647
    [No Abstract]   [Full Text] [Related]  

  • 44. Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.
    Lucchesi BR; Haley NR
    Eur J Pharmacol; 1973 Jun; 22(3):256-62. PubMed ID: 4732564
    [No Abstract]   [Full Text] [Related]  

  • 45. Involvement of adrenergic nervous influences in ouabain-induced nonuniformity of ventricular repolarization.
    Gabriel KL; Kelliher GJ; Roberts J; Overton WR
    J Pharmacol Exp Ther; 1978 Oct; 207(1):1-7. PubMed ID: 702332
    [No Abstract]   [Full Text] [Related]  

  • 46. Protective effect of verapamil upon ouabain-induced cardiac arrhythmias.
    Khatter JC; Navaratnam S; Hoeschen RJ
    Pharmacology; 1988; 36(6):380-9. PubMed ID: 3420160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective action of methyldopa against ouabain-induced cardiac arrhythmias and lethality.
    Thomas GP; Stephen PM
    Arch Int Pharmacodyn Ther; 1993; 323():23-31. PubMed ID: 8250641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the mechanism of ouabain toxicity in Purkinje and ventricular muscle fibers at rest and during activity.
    Polimeni PI; Vassalle M
    Am J Cardiol; 1971 Jun; 27(6):622-9. PubMed ID: 5088768
    [No Abstract]   [Full Text] [Related]  

  • 49. Cocaine suppression of triggered activity. A possible mechanism of antiarrhythmic action.
    Carpentier RG; Sherief HT
    J Electrocardiol; 1994 Jan; 27(1):35-9. PubMed ID: 8120476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of autonomic neurotransmitters on automaticity in ventricular myocardium.
    Hume JR; Katzung BG
    Proc West Pharmacol Soc; 1977; 20():257-62. PubMed ID: 896832
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactions of quazodine with cardiotoxic doses of ouabain in the anesthetized dog.
    Gomoll AW; Byrne JE; McKinney GR
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):16-27. PubMed ID: 4151046
    [No Abstract]   [Full Text] [Related]  

  • 52. Contribution of mechanical factors to arrhythmogenesis in calcium overloaded cardiomyocytes: model predictions and experiments.
    Katsnelson LB; Solovyova O; Balakin A; Lookin O; Konovalov P; Protsenko Y; Sulman T; Markhasin VS
    Prog Biophys Mol Biol; 2011 Oct; 107(1):81-9. PubMed ID: 21699912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of glucagon on the transmembrane potential, contraction, and ATPase activity of the failing human heart.
    Prasad K
    Cardiovasc Res; 1972 Nov; 6(6):684-95. PubMed ID: 4266319
    [No Abstract]   [Full Text] [Related]  

  • 54. Relationship of stimulation frequency to automaticity in the canine Purkinje fiber during ouabain administration.
    Hogan PM; Wittenberg SM; Klocke FJ
    Circ Res; 1973 Mar; 32(3):377-84. PubMed ID: 4691343
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of glucose on the transmembrane action potential of guinea-pig papillary muscle. Metabolic inhibitors, ouabain, and calcium chloride, and their interaction with glucose, sympathomimetic amines, and aminophylline.
    Prasad K; MacLeod DP
    Circ Res; 1969 Jun; 24(6):939-50. PubMed ID: 5786796
    [No Abstract]   [Full Text] [Related]  

  • 56. Arrhythmic movements of myocardial cells in culture and their improvement with antiarrhythmic drugs.
    Goshima K
    J Mol Cell Cardiol; 1976 Mar; 8(3):217-38. PubMed ID: 768496
    [No Abstract]   [Full Text] [Related]  

  • 57. Phase-invariant signature algorithm: a noninvasive technique for early detection and quantification of ouabain-induced cardiac disorders.
    Prasad K; Gupta MM
    Angiology; 1979 Nov; 30(11):721-32. PubMed ID: 507458
    [No Abstract]   [Full Text] [Related]  

  • 58. [Preclinical study of the pharmacodynamic and toxicologic effects of the antiarrhythmic agent, mexiletine].
    Jezek L; Urbánková G; Gasparík J; Hudcovicová E; Nosál R; Hesek D; Rybár A; Mahrla Z
    Bratisl Lek Listy; 1986 Feb; 85(2):152-9. PubMed ID: 3955401
    [No Abstract]   [Full Text] [Related]  

  • 59. A possible mechanism of the antiarrhythmic action of glucagon.
    Wilkerson RD; Partlow DB; Pruett JK; Patterson CW
    Eur J Pharmacol; 1977 Jul; 44(1):57-63. PubMed ID: 885159
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiac glycosides and contractility.
    Lüllmann H; Peters T
    Adv Cardiol; 1974; 12(0):174-82. PubMed ID: 4275965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.